Apnimed, Inc. Common Stock (APMD) — Cash Flow-to-Debt Ratio
Apnimed, Inc. Common Stock (APMD) has a Cash Flow-to-Debt Ratio of -0.23x as of March 2026, meaning its operating cash flow of $-19.81 Million could theoretically repay 0% of its total liabilities ($85.04 Million) in one year. For the full cash flow conversion analysis, see Apnimed, Inc. Common Stock operating cash flow efficiency.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Apnimed, Inc. Common Stock Cash Flow-to-Debt Ratio (2024–2025)
Historical debt coverage capacity for Apnimed, Inc. Common Stock across 2 annual periods. See financial flexibility index of Apnimed, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
Annual Cash Flow-to-Debt Ratio for Apnimed, Inc. Common Stock (2024–2025)
Year-by-year debt coverage analysis for Apnimed, Inc. Common Stock. Check Apnimed, Inc. Common Stock earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.17x | $-77.83 Million | $445.66 Million | ▲ +43.3% |
| 2024 | -0.31x | $-110.21 Million | $357.84 Million | — |